Document is current
Any future updates will be listed below
-
Authors
Merikallio, Heta https://orcid.org/0000-0002-0967-3987
Kreus, Mervi
Lehtonen, Siri T.
Kangas, Salla M.
Heikkinen, Anne
Uusimaa, Johanna
Hallman, Mikko
Hinttala, Reetta
Kaarteenaho, Riitta
-
Funding
Funding for this research was provided by:
Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö
Tampereen Tuberkuloosisäätiö
Jalmari ja Rauha Ahokkaan Säätiö
Research Foundation of North Finland
Hengityssairauksien Tutkimussäätiö
Academy of Finland (311934, 331436)
Lastentautien Tutkimussäätiö
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 20 August 2025
First Online: 26 September 2025
Declarations
:
: This study has been approved by the ethics committee of the Northern Ostrobothnia hospital district (EETTMK no. 68/2017, and EETTMK 65/2021).
: Not applicable.
: HM, MK, SL, MH, and RH have no conflict of interest to declare. RK reports consulting and lecture fees from Boehringer Ingelheim and MSD, and virtual congress cost from Roche and Novartis. JU has received virtual congress costs from Biogen.
